openPR Logo
Press release

Epidural Abscess Treatment Market Forecast 2024-2031: Early Detection Tools and Antibiotic Protocols Drive Growth | Alembic Ltd, Eli Lilly and Company, Sandoz Group Inc.

07-15-2025 02:29 PM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research LLP

Epidural Abscess Treatment

Epidural Abscess Treatment

"The epidural abscess treatment market is projected to grow from $41.11 billion in 2024 to $56.78 billion by 2029, registering a strong CAGR of 6.6% - 7.1%," according to DataM Intelligence.

The Epidural Abscess Treatment Market features a diverse mix of global pharmaceutical and device leaders. Alembic Ltd, Sun Pharmaceutical, Sandoz, and Novartis contribute with broad-spectrum antibiotic portfolios and spinal infection therapies. Device and diagnostic sophistication come from Eli Lilly, Siemens Healthineers, Abbott, Merck, and Pfizer, which offer imaging systems, infection-detection tools, and biologics. Meanwhile, Sanofi focuses on specialty antibiotic development. Strategic R&D and integrated solutions are defining competitive dynamics.

Download your exclusive sample report today: https://www.datamintelligence.com/download-sample/epidural-abscess-treatment-market?jd

Epidural Abscess Treatment Market M&A & Strategic Collaborations

1. Siemens Healthineers acquires MRI startup Axon Imaging (June 2025) to enhance spinal infection diagnostics and support early epidural abscess detection.
2. Novartis-Sandoz antibiotic portfolio licensing deal (May 2025) expands global distribution rights for spinal infection therapeutics across emerging markets.
3. Sun Pharmaceutical partners with a US spine-tech firm (July 2025) to develop minimally invasive antibiotic delivery devices specifically targeting epidural abscess treatment.

These moves highlight a trend toward diagnostic and therapeutic integration, portfolio expansion through licensing, and health-tech partnerships targeting infection control and spinal care.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/epidural-abscess-treatment-market?jd

Key Growth Drivers & Emerging Opportunities in the Epidural Abscess Treatment Market

• Rising incidence of hospital-acquired spinal infections demands improved treatment protocols
• Advancements in MRI/CT and AI diagnostics enabling early detection and precise intervention
• Growing adoption of minimally invasive surgical and antibiotic delivery platforms
• Increased hospital surveillance and antimicrobial stewardship programs
• Emergence of localized antibiotic delivery systems and robotic-assisted devices opens new treatment avenues

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=epidural-abscess-treatment-market?jd

Regional Market Drivers for Epidural Abscess Treatment

North America leads with advanced hospital infrastructure, high imaging access, and supportive reimbursement for spine infection care.
Europe benefits from strong infection surveillance programs, state-funded healthcare, and adoption of minimally invasive surgical protocols.
Asia-Pacific is growing rapidly, driven by enhanced diagnostic infrastructure, growing MRI installations, and rising spinal surgery rates.
Latin America, and Middle East & Africa are emerging markets, supported by advancing hospital capabilities and international partnerships in infection management.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drug Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains, creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Epidural Abscess Treatment Market Forecast 2024-2031: Early Detection Tools and Antibiotic Protocols Drive Growth | Alembic Ltd, Eli Lilly and Company, Sandoz Group Inc. here

News-ID: 4104914 • Views:

More Releases from DataM Intelligence 4Market Research LLP

Bio-Based Molecule Market Driven by Sustainability Goals and Rising Demand for Biodegradable Alternatives by 2031
Bio-Based Molecule Market Driven by Sustainability Goals and Rising Demand for B …
"The Global Bio-based Molecule Market reached US$1,336.72 million in 2023 and is expected to reach US$2,437.83 million by 2031, growing with a CAGR of 7.8% during the forecast period 2024-2031," according to DataM Intelligence. The Bio-Based Molecule Market is spearheaded by leading industrial biotech firms, including Arkema, Covestro, and Borregaard, backed by global engineering groups like GEA Group and DE Smet Engineers. AVA Biochem, Jiangmen Xinshuo, and NTIC excel in fine
Human Immunodeficiency Virus Type 1 Treatment Market Expands with Breakthrough HIV Vaccines and Gene Therapy Trials
Human Immunodeficiency Virus Type 1 Treatment Market Expands with Breakthrough H …
"Global Human Immunodeficiency Virus Type-1 (HIV-1) Treatment Market reached US$39,670.14 million in 2023 and is expected to reach US$62,752.56 million by 2031, growing at a CAGR of 5.9% during the forecast period 2024-2031," according to DataM Intelligence. The HIV 1 treatment market is dominated by established pharmaceutical leaders such as Gilead Sciences, ViiV Healthcare, Janssen, Viatris, and Merck, which offer a wide range of antiretroviral therapies (ARTs), including fixed-dose combinations and
Veterinary Surgical Sutures Market Innovation Accelerates with Biodegradable Materials and Smart Sutures | B. Braun Medical Ltd, Medtronic, CP Medical, Vitrex Medical A/S, Air-Tite Products Co., Inc.
Veterinary Surgical Sutures Market Innovation Accelerates with Biodegradable Mat …
"The Global Veterinary Surgical Sutures Market reached US$178.6 million in 2023 and is expected to reach US$284.7 million by 2031, growing with a CAGR of 6% during the forecast period 2024-2031," according to DataM Intelligence. The Veterinary Surgical Sutures market is led by reputable medical device manufacturers, including B. Braun, Medtronic, CP Medical, Vitrex Medical, and Air-Tite Products, all offering a wide range of suture types for animal surgery. Johnson &
Pemphigus Vulgaris Treatment Market Expands with Novel Anti-CD20 Antibody Approvals in 2025 | F. Hoffmann-La Roche Ltd, Pfizer Inc, Teva Pharmaceutical Industries
Pemphigus Vulgaris Treatment Market Expands with Novel Anti-CD20 Antibody Approv …
"The Global Pemphigus Vulgaris Treatment Market reached US$473.4 million in 2023 and is expected to reach US$896.1 million by 2031, growing with a CAGR of 8.3% during the forecast period 2024-2031," according to DataM Intelligence. The Pemphigus Vulgaris treatment market features a strong lineup of pharmaceutical leaders and emerging biotech innovators. Roche, Pfizer, Novartis, Sanofi, AbbVie, and AstraZeneca dominate with their biologic and immunomodulatory portfolios. Teva, GSK, and Zydus Group bolster

All 5 Releases


More Releases for Epidural

Epidural Catheter Market Trends, Industry Analysis, Growth and Forecast - 2027
An epidural catheter is a very fine plastic catheter (tube) that is inserted through the skin into the epidural space of the spine. This temporary catheter remains in place for a set amount of time. Usually less than 2 weeks. The catheter provides access to the epidural space and allows injection of medications such as local anesthetics and/or drugs to relieve pain. Epidural Catheter market size is projected to reach US$
Epidural Anesthesia NeedlesMarket Size, Share, Development by 2024
Global Info Research offers a latest published report on Epidural Anesthesia NeedlesMarket Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Epidural Anesthesia Needlesplayers, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Epidural Anesthesia Needleswith respect to individual growth
Epidural Anesthetic Device Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Epidural Anesthetic Device Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Epidural Anesthetic Device players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Epidural Anesthetic Device with respect
Epidural Anaesthesia System Market Growth Dynamics During 2017 - 2025
Epidural anaesthesia, also known as regional anesthesia is a type of anesthesia that is injected at the back of the body. It blocks all responses to nerve impulses from the lower spinal segments, which results in decreased sensation in lower half of the body. Epidural anesthesia medications are of local anesthetics and are delivered in combination with opioids, in order to decrease the required dose of local anaesthetic. Epidural anesthesia
01-15-2018 | Health & Medicine
TMR
Epidural Anesthesia Sets Market Size and Forecast 2025
Epidural anesthesia, also known as regional anesthesia or epidurals, is administered through the intravenous route to block pain signals of a particular region of the body. The aim of epidural anesthesia is to impart an analgesic effect, leading to complete absence of sensation in that part of the body. The epidural anesthesia generally blocks pain signals from the lower spine, decreasing the sensation in lower half of the body. The
Epidural Anesthesia Sets Market Set to Surge Significantly During 2025
Epidural anesthesia, also known as regional anesthesia or epidurals, is administered through the intravenous route to block pain signals of a particular region of the body. The aim of epidural anesthesia is to impart an analgesic effect, leading to complete absence of sensation in that part of the body. The epidural anesthesia generally blocks pain signals from the lower spine, decreasing the sensation in lower half of the body. The